Empirica Therapeutics

Empirica Therapeutics is a company developing immunotherapies to treat cancers. It utilizes a genomics platform combined with patient-based models of brain cancer and recurrence. The company is focused on the development of adoptive immunotherapies against glioblastoma (GBM) and brain metastasis (BM).